Henrich Jill (CIK 0001978096)

Latest company ownership

ATRA - Atara Biotherapeutics, Inc.

Role: EVP, Chief Regulatory Officer

Shares held

18,679

Last filed at

Mar 5, 2025

Confidence Score

50.0

2025Q4

Confidence Score History

2023Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 3, 2025	Mar 5, 2025	Atara Biotherapeutics, Inc.	EVP, Chief Regulatory Officer	Sell	47.5	-1,059	-5.37%	✗	$7.4K
Nov 18, 2024	Nov 20, 2024	Atara Biotherapeutics, Inc.	EVP, Chief Regulatory Officer	Sell	46.3	-1,000	-4.91%	✗	$11.2K
Aug 16, 2024	Aug 20, 2024	Atara Biotherapeutics, Inc.	EVP, Global Head RA & Quality	Sell	47.5	-963	-4.51%	✗	$6.4K
May 16, 2024	May 20, 2024	Atara Biotherapeutics, Inc.	EVP, Global Head RA & Quality	Sell	46.3	-25,750	-4.64%	✗	$15.9K
Mar 4, 2024	Mar 6, 2024	Atara Biotherapeutics, Inc.	EVP, Global Head RA & Quality	Sell	50.0	-3,879	-0.69%	✗	$2.8K
Nov 16, 2023	Nov 20, 2023	Atara Biotherapeutics, Inc.	EVP, Global Head RA & Quality	Sell	47.5	-3,267	-3.03%	✗	$1.3K
Aug 16, 2023	Aug 18, 2023	Atara Biotherapeutics, Inc.	EVP, Global Head RA & Quality	Sell	47.5	-3,346	-3.01%	✗	$5.5K